Some decisions still to be made about this, but likely want to use something similar to the correlation parameter for humoral / mucosal immunity overlap.
Main decision: do we implement SIA's completely post-hoc, after RI-based immunity is estimated (likely for first-draft) OR do we encode assumptions about source of immunity. This is because in reality SIA can be source of immunity even for a child who receives full RI schedule; however with simplistic assumptions about it shouldn't make a difference so long as we don't try to allocate sources of immunity.
Other decisions:
- input data format
- parameterisation of overlap
Some decisions still to be made about this, but likely want to use something similar to the correlation parameter for humoral / mucosal immunity overlap.
Main decision: do we implement SIA's completely post-hoc, after RI-based immunity is estimated (likely for first-draft) OR do we encode assumptions about source of immunity. This is because in reality SIA can be source of immunity even for a child who receives full RI schedule; however with simplistic assumptions about it shouldn't make a difference so long as we don't try to allocate sources of immunity.
Other decisions: